Navigation
banner

The Opioid Crisis and Alternatives

2018-01-232018-03-272018-02-08
EARLY BIRD DISCOUNT! Register by Feb 08, 2018 to receive 20% off your registration!
Or Register 3 for the price of 2 with the coupon code rcdvb!


KEYNOTE SPEAKERS
Christopher Jones

Christopher Jones
Director, National Mental Health and Substance Use Policy Laboratory
SAMHSA
Christopher Jones
Director, National Mental Health and Substance Use Policy Laboratory
SAMHSA
 
About Speaker:

Christopher M. Jones, PharmD, MPH Director, National Mental Health and Substance Use Policy Laboratory Substance Abuse and Mental Health Services Administration U.S. Department of Health and Human Services

Christopher M. Jones serves as the Director of the National Mental Health and Substance Use Policy Laboratory at the Substance Abuse and Mental Health Services Administration (SAMHSA). The Policy Lab, created in the 21st Century Cures Act, is charged with identifying, coordinating, and facilitating the implementation of policy changes likely to have a significant effect on mental health, mental illness, recovery supports, and the prevention and treatment of substance use disorders, and working to advance innovation and the dissemination and adoption of evidence-based practices and programs related to mental health and substance abuse. Prior to joining SAMHSA, Dr. Jones served as Acting Associate Deputy Assistant Secretary for Science and Data Policy and Director of the Division of Science Policy in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health and Human Services. The Office of Science and Data Policy is the HHS focal point for policy research, analysis, evaluation, and coordination of public health, science, and data policy activities, and provides authoritative advice and analytical support to HHS leadership on public health, science, and data policy issues and initiatives. He has also served as senior advisor in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA) and led the Centers for Disease Control and Prevention’s (CDC) drug abuse and overdose activities where he focused on strategic policy development and implementation, engaging national and state partners, and conducting research to improve policy and clinical practice. During his career, Dr. Jones has served as Senior Public Health Advisor to the White House Office of National Drug Control Policy, led the FDA’s Drug Safety and Risk Communication team, and served on the Science Team in the CDC’s Strategic National Stockpile. He received his Bachelor of Science degree from Reinhart College, his Doctor of Pharmacy degree from Mercer University, his Master of Public Health degree from New York Medical College, and is currently completing his Doctorate of Public Health in Heath Policy at The George Washington University Milken Institute School of Public Health. Dr. Jones has authored more than 50 peer-reviewed publications on the topic of drug abuse and overdose.

DISTINGUISHED SPEAKERS
Edward Bilsky

Edward Bilsky
Provost & Chief Academic Officer
Pacific Northwest University of Health Sciences
Edward Bilsky
Provost & Chief Academic Officer
Pacific Northwest University of Health Sciences
 
About Speaker:
Richard Boxer

Richard Boxer
Founder and Managing Partner, Boxer Health Strategies
Professor, Clinical Urology, UCLA School of Medicine
Richard Boxer
Founder and Managing Partner, Boxer Health Strategies
Professor, Clinical Urology, UCLA School of Medicine
 
About Speaker:

Richard Boxer, MD was the original Chief Medical Officer of Teladoc from 2006-2013. He presently consults with numerous telemedicine companies. He is a guest speaker on telemedicine around the US, and also consults with European and Asian companies in telemedicine.

Dr. Boxer is the medical advisor to iAnthus Capital Holdings, a Canadian/US company that provides investors diversified exposure to best-in-class licensed cannabis cultivators, processors, and dispensaries throughout the United States.

iAnthus operates in 6 states, potentially comprising 7 cultivation facilities, 15 dispensaries and 4 processing facilities.

As Clinical Professor of Urology at the David Geffen School of Medicine at UCLA, Dr. Boxer is an international leader in telemedicine and a national leader in health policy.  He graduated from the University of Wisconsin undergraduate and medical schools with high honors and completed his training at UCLA in urology. He has been a health policy adviser to the White House, Senators and Governors.  He was appointed to the Boards of the National Cancer Institute and the National Institute of Diabetes, Kidney, and Digestive Diseases. As a private citizen, he represented the US at the World Health Organization.  He was finalist for Surgeon General of the US in 1997 and 2001 under the Clinton and Bush Administrations.  Dr Boxer has had OP-EDs recently published in the Wall Street Journal three times (http://www.wsj.com/articles/when-a-doctor-is-always-a-phone-call-away-1438551044 and https://www.wsj.com/articles/itll-take-more-than-a-band-aid-to-fix-medicaid-1486336355, and https://www.wsj.com/articles/can-marijuana-alleviate-the-opioid-crisis-1511104543), the New York Times (http://www.nytimes.com/2016/11/02/opinion/how-health-care-hurts-your-paycheck.html?_r=0), and JAMA (http://jamanetwork.com/journals/jama/fullarticle/2607482), all on health policy.

Dr Boxer is a consultant for many of the telemedicine companies that are established and start-ups, VCs, equity partners, companies that want to start a telemedicine company, companies that want to hire a telemedicine company, insurance companies that want to evaluate telemedicine companies, and health systems and doctor groups that want to understand the telemedicine industry.  

He has a deep and broad understanding of the telemedicine and cannabis industries and is a consultant, speaker, thought-leader, and author of the opportunities within the industries.

Christopher Evans

Christopher Evans
Director, Brain Research Institute; Professor, Psychiatry and Biobehavioral Sciences
UCLA
Christopher Evans
Director, Brain Research Institute; Professor, Psychiatry and Biobehavioral Sciences
UCLA
 
About Speaker:
Mireille Jacobson

Mireille Jacobson
Associate Professor, The Paul Merage School of Business; Director, Center for Health Care Management and Policy
UC Irvine
Mireille Jacobson
Associate Professor, The Paul Merage School of Business; Director, Center for Health Care Management and Policy
UC Irvine
 
About Speaker:
Anthony Okorodudu

Anthony Okorodudu
Professor, Pathology
University of Texas Medical Branch
Anthony Okorodudu
Professor, Pathology
University of Texas Medical Branch
 
About Speaker:

Anthony O. Okorodudu, PhD, MBA, DABCC, FACB

Professor Anthony O. Okorodudu obtained his doctorate degree in Pathology (1982; University of Medicine and Dentistry of New Jersey) following an undergraduate degree from Rutgers University. He also holds an MS degree in Management, Computing, and Systems (Houston Baptist University), MBA degree (Rice University), and completed his fellowship training in Clinical Chemistry at Hartford Hospital in Hartford, CT. Professor Okorodudu is a Diplomate of the American Board of Clinical Chemistry and a Fellow of National Academy of Clinical Biochemistry.

His professional career includes service as Lecturer I at the Department of Chemical Pathology, School of Medicine, University of Benin (1982-1986), and Immunochemist/Fellow, Clinical Chemistry Division, Hartford Hospital, CT (1986-1988). Since 1989, he has been with the University of Texas System (UTMB), where he is Professor of Pathology and Director of Clinical Chemistry Division for UTMB Hospitals and Correctional Clinical Laboratories for UTMB/Texas Department of Criminal Justice, Pathology Clients Services Division, ComACC-Accredited Postdoctoral Training Program in Clinical Chemistry, and Pathology Residents Training in Clinical Chemistry. He is also on the faculty of the UTMB Graduate School of Biomedical Sciences where he has supervised the PhD dissertations for several students (including one from University of Benin). He has published extensively with more than 100 peer-reviewed papers, several book chapters, and over 100 abstracts. His research focus is in the elucidation of the pathophysiology of intracellular ions in the pathology of drug-drug interactions.

Professor Okorodudu is very active in his professional associations at the national level where he served on the AACC Board of Directors from 2002 – 2006. He also served the International Federation of Clinical Chemistry as Chair of the Committee on Point of Care Testing. His other international professional involvements include current and immediate past service as reviewer for several medical/scientific journals and service on the Board of Editors for the following journals: Clinical Lab News, Clin Chim Acta, POCT, Journal of Pediatric Biochemistry, and Open Clinical Chemistry. His professional accomplishments have been widely recognized with awards that include the “2001 Distinguished Alumni Award” from the Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey. He is also the recipient of the “Role Model Award” from Minority Access, Inc. (in cooperation with the Office of Minority Health, National Institute of Health), AACC International Travel Award, and the TX AACC Clinical Chemist Award.

Together with his wife, Osato, they have four children and eight grandchildren.

Matthew Torrington

Matthew Torrington
Family and Addiction Medicine Physician
Private Practice
Matthew Torrington
Family and Addiction Medicine Physician
Private Practice
 
About Speaker:

Matthew A. Torrington, MD, is the Medical Director at the Common Ground/End Dependence Free Clinic in Santa Monica, California, the Chief of Addiction Medicine at the Avalon Malibu Residential treatment center in Malibu California and a Consulting Addiction Medicine Physician at Cri Help in North Hollywood. Dr. Torrington maintains a private practice focusing on the longitudinal disease management of difficult addiction and pain cases.

Dr Torrington’s clinical focus is on the treatment of stimulant dependence, alcohol dependence, opiate dependence, and pain. A participant in the development and implementation of significant research studies, he has served as Principle Investigator, co-investigator or study physician on numerous clinical trials.

Dr Torrington has authored and coauthored numerous articles published in peer-reviewed journals, such as the Journal of the Experimental Analysis of Behavior, Journal of Addiction Medicine, Addiction Biology, Journal of Addictive Diseases, and Drug and Alcohol Dependence.

Dr Torrington is a boarded by the American Academy of Family Medicine and the American Board of Addiction Medicine. He is a member of the American Society of Addiction Medicine, the California Society of Addiction Medicine and the American Academy of Pain Management. He is a member of the Committee on Treatment of Opioid Dependence of the California Society of Addiction Medicine and is a certified Medical Review Officer.

Elizabeth Whalley Buono

Elizabeth Whalley Buono
Practice Head, Process & Innovation Management
Kinexum
Elizabeth Whalley Buono
Practice Head, Process & Innovation Management
Kinexum
 
About Speaker: